Liu J - Search Results

1

Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention.

Yu S, Yan C, Yang X, He S, Liu J, Qin C, Huang C, Lu Y, Tian Z, Jia L. Yu S, et al. Among authors: liu j. Sci Rep. 2016 Mar 2;6:22388. doi: 10.1038/srep22388. Sci Rep. 2016. PMID: 26932781 Free PMC article.

2

In vitro and in vivo efficacy and safety evaluation of metapristone and mifepristone as cancer metastatic chemopreventive agents.

Wang J, Chen J, Zhu Y, Zheng N, Liu J, Xiao Y, Lu Y, Dong H, Xie J, Yu S, Shao J, Jia L. Wang J, et al. Among authors: liu j. Biomed Pharmacother. 2016 Mar;78:291-300. doi: 10.1016/j.biopha.2016.01.017. Epub 2016 Feb 4. Biomed Pharmacother. 2016. PMID: 26898454

3

Thirty-day rat toxicity study reveals reversible liver toxicity of mifepristone (RU486) and metapristone.

Xiao Y, Zhu Y, Yu S, Yan C, Ho RJ, Liu J, Li T, Wang J, Wan L, Yang X, Xu H, Wang J, Tu X, Jia L. Xiao Y, et al. Among authors: liu j. Toxicol Mech Methods. 2016;26(1):36-45. doi: 10.3109/15376516.2015.1118715. Epub 2016 Feb 23. Toxicol Mech Methods. 2016. PMID: 26907462

4

Aptamer-Conjugated Chitosan-Anchored Liposomal Complexes for Targeted Delivery of Erlotinib to EGFR-Mutated Lung Cancer Cells.

Li F, Mei H, Xie X, Zhang H, Liu J, Lv T, Nie H, Gao Y, Jia L. Li F, et al. Among authors: liu j. AAPS J. 2017 May;19(3):814-826. doi: 10.1208/s12248-017-0057-9. Epub 2017 Feb 23. AAPS J. 2017. PMID: 28233244

5

Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.

Zheng N, Chen J, Li T, Liu W, Liu J, Chen H, Wang J, Jia L. Zheng N, et al. Among authors: liu j, liu w. Mol Carcinog. 2017 Aug;56(8):1896-1908. doi: 10.1002/mc.22645. Epub 2017 Mar 30. Mol Carcinog. 2017. PMID: 28277622

6

Metapristone (RU486 derivative) inhibits cell proliferation and migration as melanoma metastatic chemopreventive agent.

Zheng N, Chen J, Liu W, Wang J, Liu J, Jia L. Zheng N, et al. Among authors: liu j, liu w. Biomed Pharmacother. 2017 Jun;90:339-349. doi: 10.1016/j.biopha.2017.03.076. Epub 2017 Apr 2. Biomed Pharmacother. 2017. PMID: 28376402

7

Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway.

Zheng G, Shen Z, Chen H, Liu J, Jiang K, Fan L, Jia L, Shao J. Zheng G, et al. Among authors: liu j. Biomed Pharmacother. 2017 Jun;90:437-445. doi: 10.1016/j.biopha.2017.03.091. Epub 2017 Apr 6. Biomed Pharmacother. 2017. PMID: 28391165

8

Global deregulation of ginseng products may be a safety hazard to warfarin takers: solid evidence of ginseng-warfarin interaction.

Dong H, Ma J, Li T, Xiao Y, Zheng N, Liu J, Gao Y, Shao J, Jia L. Dong H, et al. Among authors: liu j. Sci Rep. 2017 Jul 19;7(1):5813. doi: 10.1038/s41598-017-05825-9. Sci Rep. 2017. PMID: 28725042 Free PMC article.

9

Mifepristone inhibits ovarian cancer metastasis by intervening in SDF-1/CXCR4 chemokine axis.

Zheng N, Chen J, Liu W, Liu J, Li T, Chen H, Wang J, Jia L. Zheng N, et al. Among authors: liu j, liu w. Oncotarget. 2017 Jul 17;8(35):59123-59135. doi: 10.18632/oncotarget.19289. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938623 Free PMC article.

10

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway.

Shao J, Zheng G, Chen H, Liu J, Xu A, Chen F, Li T, Lu Y, Xu J, Zheng N, Jia L. Shao J, et al. Among authors: liu j. Oncotarget. 2017 Jun 27;8(45):78351-78364. doi: 10.18632/oncotarget.18640. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108234 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146,764 results

Search Page

Filters